Neuromodulation Devices Market: By Technology, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimulation, Others), By Application, and Geography
Neuromodulation Devices Market size was valued at US$ 6,334.9 million in 2023 and is poised to grow at a CAGR of 6.3% from 2024 to 2030. Neuromodulation is a technology that acts directly upon nerves. It is the alteration or modulation of nerve activity by delivering electrical or pharmaceutical agents directly to a target area. The key factors driving the neuromodulator devices are the rising prevalence of moment disorders, epilepsy, pain, and depression. Additionally, Factors such as the increasing prevalence of neurological disorders, the rise in the aging population, and novel symptoms and prolonged target applications are mostly anticipated to fuel the market growth during the forecast period.
Furthermore, the number of people suffering from dementia and other neurological disorders is increasing globally, and it is anticipated to generate lucrative prospects for the adaptation and development of neuromodulation technologies and techniques. Moreover, the collaboration between the hospitals, clinics, and market players is anticipated to drive the market in the forecast period.
However, the challenges associated with the market are the high cost associated with the devices, some of the risks that may occur if neuromodulation devices are implanted in the body are bleeding, infection, blood clots and reaction to the medication remains substantial barriers that hamper the demand for the market in the forecast period. However, the key opportunities associated with neuromodulation devices are the rising prevalence of neurological disorders, psychiatric disorders, movement disorders, bladder and bowel dysfunction, and sleep disorders, and emerging applications and indications generate lucrative opportunities for neuromodulation devices in the forecast period.
Study Period
2024 - 2030Base Year
2023CAGR
6.3%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increasing prevalence of neurological disorders including Parkinson’s disease, stroke, Alzheimer’s, CNS in the body, cerebrovascular diseases, and tremors affect the PNS and neuromodulation is an efficient way to manage these diseases, sequentially, is anticipated to drive the neuromodulation devices market in the forecast period. furthermore, unending technological advancements in the neuromodulation devices technology, enhancements in the device designs, electrode materials, stimulation algorithms, and programming interfaces, subsidize the enlargement of the market.
Additionally, inventive features such as closed-loop stimulation, wireless connectivity, and miniaturization augment device performance, efficacy, and patient comfort, which in turn is anticipated to drive the market in the forecast period. For instance, as per the fact sheet by the WHO (World Health Organization), approximately 55 million people globally suffer from epilepsy and nearly 2.4 million cases are diagnosed annually. Consequently, with the rising cases of neurological diseases, the stipulation for neuromodulation devices is anticipated to rise over the forecast period.
Based on regions, the Neuromodulation Devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The market in the North America is likely to hold a major revenue share in 2023, and, in the following years, it is predicted to increase rapidly owing to the rising number of patients suffering from neurological diseases, which in turn, is rising the necessity for the adaptation of the neuromodulation devices, augmented competition among the market players, and substantial expenditure on research and development to generate innovative therapeutic solutions are subsidizing the market growth in the developed economies especially in the North America.
Additionally, there has been a sturdy evolution in the number of patients with neurological disorders from several provisions in the US and Canada, sequentially, fueling the demand for the market in the forecast period. Asia Pacific is likely to hold a considerable market share in the global market and is expected to grow at a significant CAGR over the forecast years
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024 - 2030 |
|
Market Size in 2023 |
US$ 6,334.9 million |
|
Market CAGR |
6.3% |
|
By Technology |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
Neuromodulation devices market size was valued at US$ 6,334.9 million in 2023 and is set to grow at a CAGR of 6.6% during the forecast period 2024-2030.
North America is expected to dominate the Neuromodulation Devices market.
Medtronic, Boston Scientific Corporation, Abbott, Nevro Corporation, Neurosigma Inc., Neuropace Inc., Neuronetics, Inc., LivaNova PLC, BioControl Medical, soterix medical, Inc., Integer holdings corporation, synapse biomedical, Inc.
The key factors driving the neuromodulator devices market are the increase in prevalence of neurological diseases such as chronic pain and depression, raised investments by the private players for research and development of neuromodulation devices, and the rising number of healthcare expenditure are some of the factors driving demand for the growth of the global neuromodulator devices market
| 1. Executive Summary |
| 2. Global Neuromodulation Devices Market Introduction |
| 2.1. Global Neuromodulation Devices Market - Taxonomy |
| 2.2. Global Neuromodulation Devices Market -Definitions |
| 2.2.1. Technology |
| 2.2.2. Application |
| 3. Global Neuromodulation Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Neuromodulation Devices Market Dynamic Factors - Impact Analysis |
| 3.6. Global Neuromodulation Devices Market - Competition Landscape |
| 4. Investments Raised by Various Neuromodulation Companies |
| 5. Reimbursement Scenario |
| 6. Global Neuromodulation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 6.3. Market Opportunity Analysis |
| 7. Global Neuromodulation Devices Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. Spinal Cord Stimulation (SCS) |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Deep Brain Stimulation (DBS) |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Vagus Nerve Stimulation (VNS) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Sacral Nerve Stimulation (SNS) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Gastric Electrical Stimulation (GES) |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Others |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8. Global Neuromodulation Devices Market Forecast, By Application, 2019 - 2023 and Forecast, 2024 - 2030 |
| 8.1. Parkinson's disease |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Epilepsy |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Depression |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Dystonia |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Pain Management |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Others |
| 8.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.6.3. Market Opportunity Analysis |
| 9. Global Neuromodulation Devices Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. Italy |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Germany |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. France |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. UK |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Spain |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Rest of Europe |
| 9.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.6.3. Market Opportunity Analysis |
| 9.7. Global Neuromodulation Devices Market - Opportunity Analysis Index, By Technology, Application, and Country, 2024 - 2030 |
| 10. Italy Neuromodulation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. By Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Spinal Cord Stimulation (SCS) |
| 10.1.2. Deep Brain Stimulation (DBS) |
| 10.1.3. Vagus Nerve Stimulation (VNS) |
| 10.1.4. Sacral Nerve Stimulation (SNS) |
| 10.1.5. Gastric Electrical Stimulation (GES) |
| 10.1.6. Others |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Parkinson's disease |
| 10.2.2. Epilepsy |
| 10.2.3. Depression |
| 10.2.4. Dystonia |
| 10.2.5. Pain Management |
| 10.2.6. Others |
| 10.3. Italy Neuromodulation Devices Market - Opportunity Analysis Index, By Technology and Application, 2024 - 2030 |
| 10.4. Italy Neuromodulation Devices Market Dynamics - Trends |
| 11. Germany Neuromodulation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. By Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Spinal Cord Stimulation (SCS) |
| 11.1.2. Deep Brain Stimulation (DBS) |
| 11.1.3. Vagus Nerve Stimulation (VNS) |
| 11.1.4. Sacral Nerve Stimulation (SNS) |
| 11.1.5. Gastric Electrical Stimulation (GES) |
| 11.1.6. Others |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Parkinson's disease |
| 11.2.2. Epilepsy |
| 11.2.3. Depression |
| 11.2.4. Dystonia |
| 11.2.5. Pain Management |
| 11.2.6. Others |
| 11.3. Germany Neuromodulation Devices Market - Opportunity Analysis Index, By Technology and Application, 2024 - 2030 |
| 11.4. Germany Neuromodulation Devices Market Dynamics - Trends |
| 12. France Neuromodulation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. By Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Spinal Cord Stimulation (SCS) |
| 12.1.2. Deep Brain Stimulation (DBS) |
| 12.1.3. Vagus Nerve Stimulation (VNS) |
| 12.1.4. Sacral Nerve Stimulation (SNS) |
| 12.1.5. Gastric Electrical Stimulation (GES) |
| 12.1.6. Others |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Parkinson's disease |
| 12.2.2. Epilepsy |
| 12.2.3. Depression |
| 12.2.4. Dystonia |
| 12.2.5. Pain Management |
| 12.2.6. Others |
| 12.3. France Neuromodulation Devices Market - Opportunity Analysis Index, By Technology and Application, 2024 - 2030 |
| 12.4. France Neuromodulation Devices Market Dynamics - Trends |
| 13. UK Neuromodulation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. By Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Spinal Cord Stimulation (SCS) |
| 13.1.2. Deep Brain Stimulation (DBS) |
| 13.1.3. Vagus Nerve Stimulation (VNS) |
| 13.1.4. Sacral Nerve Stimulation (SNS) |
| 13.1.5. Gastric Electrical Stimulation (GES) |
| 13.1.6. Others |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Parkinson's disease |
| 13.2.2. Epilepsy |
| 13.2.3. Depression |
| 13.2.4. Dystonia |
| 13.2.5. Pain Management |
| 13.2.6. Others |
| 13.3. UK Neuromodulation Devices Market - Opportunity Analysis Index, By Technology and Application, 2024 - 2030 |
| 13.4. UK Neuromodulation Devices Market Dynamics - Trends |
| 14. Spain Neuromodulation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 14.1. By Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Spinal Cord Stimulation (SCS) |
| 14.1.2. Deep Brain Stimulation (DBS) |
| 14.1.3. Vagus Nerve Stimulation (VNS) |
| 14.1.4. Sacral Nerve Stimulation (SNS) |
| 14.1.5. Gastric Electrical Stimulation (GES) |
| 14.1.6. Others |
| 14.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.2.1. Parkinson's disease |
| 14.2.2. Epilepsy |
| 14.2.3. Depression |
| 14.2.4. Dystonia |
| 14.2.5. Pain Management |
| 14.2.6. Others |
| 14.3. Spain Neuromodulation Devices Market - Opportunity Analysis Index, By Technology and Application, 2024 - 2030 |
| 14.4. Spain Neuromodulation Devices Market Dynamics - Trends |
| 15. Rest of Europe Neuromodulation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 15.1. By Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 15.1.1. Spinal Cord Stimulation (SCS) |
| 15.1.2. Deep Brain Stimulation (DBS) |
| 15.1.3. Vagus Nerve Stimulation (VNS) |
| 15.1.4. Sacral Nerve Stimulation (SNS) |
| 15.1.5. Gastric Electrical Stimulation (GES) |
| 15.1.6. Others |
| 15.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 15.2.1. Parkinson's disease |
| 15.2.2. Epilepsy |
| 15.2.3. Depression |
| 15.2.4. Dystonia |
| 15.2.5. Pain Management |
| 15.2.6. Others |
| 15.3. Rest of Europe Neuromodulation Devices Market - Opportunity Analysis Index, By Technology and Application, 2024 - 2030 |
| 15.4. Rest of Europe Neuromodulation Devices Market Dynamics - Trends |
| 16. Competition Landscape |
| 16.1. Strategic Dashboard of Top Market Players |
| 16.2. Company Profiles (Introduction, Financial Analysis, Application & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 16.2.1. Medtronic |
| 16.2.2. Boston Scientific Corporation |
| 16.2.3. Abbott |
| 16.2.4. Nevro Corporation |
| 16.2.5. Neurosigma Inc. |
| 16.2.6. Neuropace Inc. |
| 16.2.7. Neuronetics, Inc., |
| 16.2.8. LivaNova PLC |
| 16.2.9. BioControl Medical |
| 17. Research Methodology |
| 18. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
